Jobs at Kyverna Therapeutics

Manage end-to-end accounts payable via the Coupa P2P platform: vendor onboarding and maintenance, invoice processing and matching, payment batching, reconciliations, vendor inquiries/escalations, 1099/ W-9/W-8 compliance, expense and corporate card support, and month-end close activities.

Lead cross-functional asset strategy across the full product lifecycle for cell therapy programs, overseeing development, process validation, manufacturing readiness, regulatory filings, launch planning, and lifecycle expansion while aligning portfolio, commercial, and technical teams and managing partnerships, timelines, risks, and budgets.

Lead global regulatory strategy for Kyverna's cell therapy portfolio across development, approval, and commercialization. Drive labeling strategy, health authority engagements (FDA, EMA), regulatory submissions (INDs, BLAs/MAAs), and cross-functional alignment with Clinical, CMC, Commercial, Market Access, and Legal. Mentor and scale the regulatory team, manage external partners, and provide regulatory input for business development and portfolio decisions to enable launch readiness and lifecycle management.

Lead discovery and early development strategy for next-generation immune cell therapies. Oversee multidisciplinary teams, evaluate and advance in vivo CAR-T and cellular engineering technologies, build external collaborations, prioritize discovery investments, and partner with clinical, regulatory, and business teams to progress candidates from discovery through IND-enabling development.

Lead development and execution of CAR T channel strategy and operations, overseeing 3PL, specialty pharmacy, distribution, state licensing, government pricing support, GTN optimization, partner governance, launch readiness, reporting, and cross-functional coordination to ensure scalable, compliant commercialization.

Senior leader accountable for integrated development and commercialization strategy of CAR-T programs. Leads lifecycle governance, cross-functional coordination, portfolio prioritization, regulatory and manufacturing readiness, risk assessment, and executive-level decision-making to advance programs from development through regulatory filings and launch.

Lead operational delivery of cell therapy clinical trials from startup through close-out. Manage timelines, budgets, vendors/CROs, cross-functional coordination, regulatory compliance, site activation, monitoring, risk mitigation, audits, and process improvements specific to cell-therapy challenges.

Lead U.S. commercial sales and go-to-market strategy for CAR-T therapies. Build and scale a specialty sales organization, drive launches and market penetration, manage field teams, collaborate cross-functionally on access and site readiness, and use analytics to monitor KPIs and optimize performance.

Lead development and execution of a risk-based enterprise compliance program supporting commercialization readiness. Build governance, policies, monitoring, third-party diligence, training, reporting, and investigations. Serve as strategic partner to executive leadership, manage cross-functional initiatives and compliance team growth, and establish metrics to evaluate program effectiveness.

Lead strategy and execution of an in-house Trial Master File (TMF) function, transitioning from outsourced to internal operations. Ensure TMFs are inspection-ready across study lifecycle, manage Veeva Vault eTMF implementations and migrations, define governance and KPIs, partner cross-functionally, and support regulatory inspections and audits.